322 related articles for article (PubMed ID: 17112415)
21. EGCG inhibits the invasion of highly invasive CL1-5 lung cancer cells through suppressing MMP-2 expression via JNK signaling and induces G2/M arrest.
Deng YT; Lin JK
J Agric Food Chem; 2011 Dec; 59(24):13318-27. PubMed ID: 22082235
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
Ohga N; Hida K; Hida Y; Muraki C; Tsuchiya K; Matsuda K; Ohiro Y; Totsuka Y; Shindoh M
Cancer Sci; 2009 Oct; 100(10):1963-70. PubMed ID: 19650861
[TBL] [Abstract][Full Text] [Related]
23. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
[TBL] [Abstract][Full Text] [Related]
24. EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells.
Kim HS; Kim MH; Jeong M; Hwang YS; Lim SH; Shin BA; Ahn BW; Jung YD
Anticancer Res; 2004; 24(2B):747-53. PubMed ID: 15161022
[TBL] [Abstract][Full Text] [Related]
25. Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells.
Singh AK; Seth P; Anthony P; Husain MM; Madhavan S; Mukhtar H; Maheshwari RK
Arch Biochem Biophys; 2002 May; 401(1):29-37. PubMed ID: 12054484
[TBL] [Abstract][Full Text] [Related]
26. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits ethanol-induced activation of pancreatic stellate cells.
Asaumi H; Watanabe S; Taguchi M; Tashiro M; Nagashio Y; Nomiyama Y; Nakamura H; Otsuki M
Eur J Clin Invest; 2006 Feb; 36(2):113-22. PubMed ID: 16436093
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
[TBL] [Abstract][Full Text] [Related]
28. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.
Yamakawa S; Asai T; Uchida T; Matsukawa M; Akizawa T; Oku N
Cancer Lett; 2004 Jul; 210(1):47-55. PubMed ID: 15172120
[TBL] [Abstract][Full Text] [Related]
29. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity.
El Fahime E; Torrente Y; Caron NJ; Bresolin MD; Tremblay JP
Exp Cell Res; 2000 Aug; 258(2):279-87. PubMed ID: 10896779
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine A inhibits the expression of membrane type-I matrix metalloproteinase in gingiva.
Chiu HC; Lu YT; Chin YT; Tu HP; Chiang CY; Gau CH; Nieh S; Fu E
J Periodontal Res; 2009 Jun; 44(3):338-47. PubMed ID: 19210333
[TBL] [Abstract][Full Text] [Related]
31. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation.
Benyon RC; Hovell CJ; Da Gaça M; Jones EH; Iredale JP; Arthur MJ
Hepatology; 1999 Oct; 30(4):977-86. PubMed ID: 10498650
[TBL] [Abstract][Full Text] [Related]
32. Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met.
Koh YW; Choi EC; Kang SU; Hwang HS; Lee MH; Pyun J; Park R; Lee Y; Kim CH
J Nutr Biochem; 2011 Nov; 22(11):1074-83. PubMed ID: 21292466
[TBL] [Abstract][Full Text] [Related]
33. (-)Epigallocatechin gallate hampers collagen destruction and collagenase activation in ultraviolet-B-irradiated human dermal fibroblasts: involvement of mitogen-activated protein kinase.
Bae JY; Choi JS; Choi YJ; Shin SY; Kang SW; Han SJ; Kang YH
Food Chem Toxicol; 2008 Apr; 46(4):1298-307. PubMed ID: 18226437
[TBL] [Abstract][Full Text] [Related]
34. 1-furan-2-yl-3-pyridin-2-yl-propenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP.
Park BC; Thapa D; Lee YS; Kwak MK; Lee ES; Choi HG; Yong CS; Kim JA
Eur J Pharmacol; 2007 Jul; 567(3):193-7. PubMed ID: 17507007
[TBL] [Abstract][Full Text] [Related]
35. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells.
Annabi B; Lachambre MP; Bousquet-Gagnon N; Page M; Gingras D; Beliveau R
Biochim Biophys Acta; 2002 Jan; 1542(1-3):209-20. PubMed ID: 11853893
[TBL] [Abstract][Full Text] [Related]
36. Green tea polyphenol (-)-epigallocatechin gallate reduces neuronal cell damage and up-regulation of MMP-9 activity in hippocampal CA1 and CA2 areas following transient global cerebral ischemia.
Park JW; Jang YH; Kim JM; Lee H; Park WK; Lim MB; Chu YK; Lo EH; Lee SR
J Neurosci Res; 2009 Feb; 87(2):567-75. PubMed ID: 18752302
[TBL] [Abstract][Full Text] [Related]
37. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
Park JM; Kim A; Oh JH; Chung AS
Carcinogenesis; 2007 Apr; 28(4):837-47. PubMed ID: 17071627
[TBL] [Abstract][Full Text] [Related]
38. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
[TBL] [Abstract][Full Text] [Related]
39. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.
Yasuda Y; Shimizu M; Sakai H; Iwasa J; Kubota M; Adachi S; Osawa Y; Tsurumi H; Hara Y; Moriwaki H
Chem Biol Interact; 2009 Dec; 182(2-3):159-64. PubMed ID: 19646978
[TBL] [Abstract][Full Text] [Related]
40. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Dec; 14(6):1399-404. PubMed ID: 16273231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]